看黄色片强奸免费的|成人动漫视频网站|欧美性爱一区二区在线看|加勒比午夜无码电影|欧美一级aaa成人网站视频|日韩成人激情视频免费看|中国无吗一级刺谢片|免费观看的黄色影片|圆产黄色大片看黄色大毛片免|日韩一级二级三级红色毛片

普洛藥業(yè)
CDMO
API & Intermediate CDMO Finished Dosage Form Aesthetic & Care Ingredients
About CDMO
普洛藥業(yè)
普洛藥業(yè)
普洛藥業(yè)
普洛藥業(yè)
普洛藥業(yè)
Top 5
player in small molecular field in China
Apeloa CDMO is the contract manufacturing focused business of Apeloa, with strategically developed its business towards becoming one of the world's premier contract service organizations. Supported by a global network of manufacturing, development, and analytical facilities, Apeloa CDMO provides world-class discovery, development, and manufacturing services for Active Pharmaceutical Ingredients (APIs), Intermediates, and Registered Starting Materials (RSMs). The company's commitment to leading-edge science, best-in-class customer service, and regulatory compliance drives its success in the CDMO industry.
420+
customers globally
3 global R&D centers: ● Boston, USA --- Function in Q2 2024; 16,000 sq ft; 40+ chemists in two years; Tech Development Platform/Lead optimization/Screening/Tox Batch preparation ● Shanghai, China --- 68,000 sq ft; 300+ chemists; Screening/Process development/optimization/CMC ● Hengdian, China --- 88,000 sq ft; 250+ chemists; Process optimization/Tech transfer/CMC
One-Stop Service
Apeloa CDMO offers comprehensive services covering the entire lifecycle, from drug discovery to commercial production. Includes Discovery Service, Chemistry Excellence, Chemical Process R&D, Custom and Commercial Production.
普洛藥業(yè)
普洛藥業(yè)
普洛藥業(yè)
Technology Platforms
Apeloa CDMO has built cutting-edge expertise and capabilities across a wide range of technical platforms to meet the market’s expectations. Our state-of-the-art facilities and expert teams ensure efficient and innovative solutions that advance customer molecules to market.
普洛藥業(yè)
普洛藥業(yè)
普洛藥業(yè)
普洛藥業(yè)
Manufacturing Capacity
8 manufacturing sites with cGMP, ISO9001, ISO14001, OSHAS18001 and IPMS certifications, 4 sites passed US FDA, 3 sites passed PMDA, 2 sites passed EDQM
Total chemical synthesis capacity: 11,000 m3 (Stainless Steel/Glass/Hastelloy/Titanium alloy/Teflon)
Total bio-production capacity: 6,570 m3 (Stainless Steel)
3 new multi-functional API workshops for parallel productions at varied scales (658 m3 in total)
High Potency API Facility for clinical & commercial scale (75 m3 in total)